Sarcopenia as a predictor of initial administration dose of afatinib in patients with advanced non‐small cell lung cancer
Abstract Background Sarcopenia has recently emerged as a new condition with increasing importance in lung cancer patients. The aim of this study was to investigate the influence of sarcopenia on tolerance and efficacy of afatinib. Methods We retrospectively evaluated 35 patients with epidermal growt...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-06-01
|
| Series: | Thoracic Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1759-7714.13934 |